CALCIWAVE NASAL SPRAY Spray
MRP: 1,999
Packaging: 60 MD
Pack Type: spray
Composition:
Calcitonin Salmon 2200IU
Indication:
Calciwave Nasal Spray is indicated for the treatment of postmenopausal osteoporosis in females greater than 5 years postmenopause with low bone mass relative to healthy premenopausal females. Calciwave Nasal Spray should be reserved for patients who refus
Description:
Calcitonin Salmon 2200 IU is a potent, synthetic polypeptide hormone that mimics the action of human calcitonin but is derived from salmon, which has greater biological activity. It is used for the treatment of osteoporosis, Paget’s disease of bone, hypercalcemia, and other conditions where inhibition of bone resorption is beneficial.
Calcitonin acts by inhibiting osteoclast activity, thereby reducing bone breakdown and calcium release into the blood. It also has analgesic properties useful in managing acute bone pain due to vertebral fractures. This strength (2200 IU) may be administered parenterally (e.g., subcutaneous or intramuscular injection) or provided in divided doses depending on the formulation.
Tags:
- Reduces bone resorption and fracture risk
- Provides pain relief in bone-related conditions
- Rapid control of high blood calcium levels
- Effective in osteoporosis and Paget’s disease
- Useful when other bone treatments are contraindicated
Usage Information
Dosage
Osteoporosis: 100 IU daily or every other day via subcutaneous or intramuscular injection Paget’s Disease: 100 IU daily Hypercalcemia: 4 IU/kg every 12 hours (adjustable up to 8 IU/kg) Administration: Inject slowly into muscle or subcutaneously as directed Monitor serum calcium levels during treatment Dosage and duration must be tailored by a healthcare provider.
Side Effects
Common side effects: Nausea or vomiting Injection site reactions (redness, swelling) Flushing or warmth Nasal irritation (if nasal form used) Serious but rare: Allergic reactions Hypocalcemia Tachyphylaxis (loss of response over time)
Contraindications
Hypersensitivity to calcitonin (salmon) or any formulation excipients Allergy to fish-derived proteins Severe hypocalcemia (correct before initiating treatment) Pregnancy and lactation (unless clearly needed) Long-term use without monitoring bone markers or calcium levels